5 CONCLUSION
7) Stomach cancer, which ranks fifth for
incidence and fourth for fatality globally, will
continue to be a major cancer in the globe in 2020,
with over 1 million new cases and an estimated
769000 deaths.
8) Total stomach cancer mortality is predicted to
decrease in all countries considered, except Czechia
and Australia. The US showed the lowest death rate
per 100000 population: 3.39% in the number of
cancer deaths, almost 7.4% since 2017-2021, while
Australia had the largest percent increase, over 4%.
9) Compared to other areas worldwide, the US
ranked first for stomach cancer’s number of deaths
(with death rates around 3.39%, which ranked fourth),
following Spain's 4838 individuals (with death rates
of 10.22%, which ranked third) and the UK people
ranked third in number of death.
10) Moreover, trends in all countries showed a
downward movement during the 2000-2021 period,
which means that advancements in both technology
and medical treatments have led to a significant
decline in the mortality rate and number of deaths
associated with stomach cancer. Higher technologies
such as enhanced early detection methods, more
precise surgical techniques, and innovative therapies
have collectively contributed to this positive trend. As
a result, fewer lives are being lost to this devastating
disease.
REFERENCES
I. Kuzmickiene, R. Everatt, Trends and age-period-cohort
analysis of upper aerodigestive tract and stomach
cancer mortality in Lithuania, Public Health, 2021,
vol.196, pp.62-68.
LCS Thuler, The Epidemiology of Stomach Cancer.In:
Morgado-Diaz JA, editor. Gastrointestinal Cancers.
Brisbane (AU): Exon Publications, 2022.
M. Ilic, I. Ilic. Epidemiology of stomach cancer. World J
Gastroenterol. 2022, vol.28, no.12, pp.1187-1203.
C. Santucci, M. Malvezzi, F. Levi, et al. Cancer mortality
predictions for 2023 in Latin America with focus on
stomach cancer. Eur J Cancer Prev. 2023, vol.32, no.4,
pp.310-321.
Y. Lin, Y. Zheng, HL. Wang, et al. Global Patterns and
Trends in Gastric Cancer Incidence Rates (1988–2012)
and Predictions to 2030. Gastroenterology, 2021, vol.
161, no. 1, pp.116–127.e8.
H. Sung, J. Ferlay, RL. Siegel, et al. Global Cancer
Statistics 2020: GLOBOCAN Estimates of Incidence
and Mortality Worldwide for 36 Cancers in 185
Countries. CA Cancer J Clin, 2021, vol.71, pp.209–
249.
WF. Anderson, CS. Rabkin, N. Turner, et al. The changing
face of noncardia gastric cancer incidence among US
non-Hispanic Whites. J Natl Cancer Inst, 2018, vol.110,
pp.608–615.
JY. Yoo, HJ. Cho, S. Moon, et al. Pickled Vegetable and
Salted Fish Intake and the Risk of Gastric Cancer: Two
Prospective Cohort Studies and a Meta-
Analysis. Cancers (Basel), 2020, vol.12.
M. Arnold, JY. Park, MC. Camargo, et al. Is gastric cancer
becoming a rare disease? A global assessment of
predicted incidence trends to 2035.
HL. Waldum, R. Fossmark. Types of Gastric Carcinomas.
Int J Mol Sci \, 2018, pp.19.
P. Bonequi, F. Meneses-Gonzalez, P. Correa, et al. Risk
factors for gastric cancer in Latin America: a meta-
analysis. Cancer Causes Control, 2013, vol.24, pp.217–
231.
EV. Heer, AS. Harper, H. Sung, et al. Emerging cancer
incidence trends in Canada: the growing burden of
young adult cancers. Cancer. 2020, vol.126, pp.4553–
4562.
DAML 2023 - International Conference on Data Analysis and Machine Learning
158